IPAR

Business Context and Reporting Period

Company: Inter Parfums, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2002
Business Overview: Inter Parfums is a global provider of prestige perfumes, mass market perfumes, cosmetics, and health and beauty aids. The company operates through a portfolio of licensed prestige brands (e.g., Burberry, Celine, Christian Lacroix) and owned mass market brands (e.g., Aziza, Intimate). Operations are headquartered in New York and Paris, with significant manufacturing and distribution activities in both the U.S. and Europe.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 16% to a record $130.4 million, driven by a 12% growth in prestige products and a 27% surge in mass market products.
• Profitability: Net income rose 16% to $9.4 million. Diluted earnings per share increased 15% to $0.47.
• Margin Compression: Gross margin declined to 46.5% from 48.4% in 2001. Management attributes this to the weaker U.S. dollar against the Euro and a higher sales mix of lower-margin mass market products.
• Debt Reduction: The company paid off all long-term debt during 2002, resulting in a debt-free balance sheet as of year-end.
• Acquisition Impact: In May 2002, the company acquired mass market fragrance brands and inventory from Tristar Corporation for approximately $6.9 million ($3.2M IP, $3.7M inventory), contributing significantly to mass market sales growth.

Guidance, Outlook, and Risks

Management Commentary & Outlook

• Product Pipeline: Management anticipates continued growth in 2003 with new launches including seasonal fragrances for Celine and Christian Lacroix, a new Burberry line, and a Diane von Furstenberg fragrance/cosmetic line in late 2003.
• Mass Market Expansion: Full-year sales of acquired Tristar brands in 2003 are expected to boost mass market revenue further.
• Dividends: The Board increased the annual cash dividend to $0.08 per share (from $0.06) in March 2003.
• Margin Expectations: If the dollar remains weak, gross margins are expected to hover around the target range of 45% to 46%.

Risks and Contingencies

• Litigation: Ongoing appeal regarding the "Ombre Rose" trademark license with Jean Charles Brosseau, S.A. A $600,000 charge was taken in 2000; management does not expect further material adverse effects.
• Tax Audits: French Tax Authorities have issued assessments aggregating $2.3 million. The company has reserved $760,000 and contests the majority of the assessment.
• Currency Risk: Approximately 23% of prestige sales are in U.S. dollars, while European operations are Euro-denominated. Fluctuations in the Euro/USD rate materially impact margins.
• Key Personnel: Operations are heavily dependent on CEO Jean Madar and President Philippe Benacin.

Investor Verification Checklist

• Tristar Integration: Verify the full-year revenue contribution of the acquired Tristar brands in 2003 and the stability of the new manufacturing supply chain following the failure of the original contract manufacturer.
• Currency Hedging: Review the effectiveness of foreign currency hedging strategies given the company's exposure to the Euro and the impact of a weak dollar on gross margins.
• Burberry Concentration: Monitor the performance of the Burberry brand, which accounted for 40.6% of total net sales in 2002, to assess concentration risk.
• License Renewals: Track upcoming expiration dates for key licenses (e.g., Burberry expires 2006) and associated minimum royalty obligations totaling $28.4 million over future years.
• Tax Resolution: Monitor the status of the French tax audit and the potential for additional charges beyond the current $760,000 reserve.